How do dental injections make your lower teeth go numb?

ISRCTN ISRCTN15594715
DOI https://doi.org/10.1186/ISRCTN15594715
Secondary identifying numbers N/A
Submission date
09/02/2012
Registration date
11/04/2012
Last edited
20/08/2015
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Oral Health
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Background and study aims
In this study we would like determine the mode of action of a local anaesthetic technique used to make the lower molar teeth numb. The local anaesthetic medicine to be used is articaine with adrenaline, a medicine commonly used by dentists.

Who can participate?
Healthy adult volunteers aged 18-30.

What does the study involve?
The volunteers must attend for three visits, at least 1 week apart. At each visit they will receive two injections, one of which will contain the medicine and the other a needle penetration only with no injection of medicine. This is so they cannot guess what anaesthetic treatment they are receiving. No more than 2 ml of medicine will be injected at each visit, which is a typical amount injected during routine dental treatment and is extremely safe. The medicine will be injected into the gum next to three teeth - the canine, first molar and second molar teeth in the lower jaw, using a standard dental syringe. After each needle penetration they will be asked to rate their discomfort. To test how numb each of five teeth in the lower jaw have become they will be tested with an ‘electronic pulp tester’, a standard device for assessing numbness of teeth. Each test will be repeated every 4 minutes for 47 minutes following the injections. We will also test some of their unaffected teeth to make sure the testing device is working properly.

What are the possible benefits and risks of participating?
Some discomfort may be experienced during the injections, the volunteers may find the feeling of numbness unpleasant and they may experience some minor bleeding into their mouth from the injection sites. They should also take care following the injection whilst the numbness is present to avoid any self-inflicted injury. Adverse reactions to the local anaesthetic are very rare but may include headache, swelling or a ‘pins and needles’ sensation once the numbness has worn off, but these are short lived and will resolve without any treatment.

Where is the study run from?
Newcastle Dental Hospital (UK).

When is the study starting and how long is it expected to run for?
February to July 2012.

Who is funding the study?
The study is funded by 3M ESPE.

Who is the main contact?
Dr JG Meechan
john.meechan@newcastle.ac.uk

Contact information

Dr John Meechan
Scientific

Oral Surgery
School of Dental Sciences
Newcastle University
Framlington Place
Newcastle Upon Tyne
NE2 4BW
United Kingdom

Study information

Study designDouble-blind placebo-controlled cross-over single-centre study
Primary study designInterventional
Secondary study designRandomised cross over trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleA double-blind cross-over trial with healthy adult volunteers comparing molar buccal infiltrations to canine buccal infiltrations for anaesthesia of mandibular teeth
Study objectivesMandibular molar infiltrations with articiane have the same mode of action as deposition of local anaesthetic solution at the mental foramen, so therefore a modified mental and incisive nerve block.
Ethics approval(s)NRES Committee North East - Newcastle and North Tyneside 1, 18/07/2011, ref: 11/NE/0050
Health condition(s) or problem(s) studiedDental local anaesthesia
Intervention1.8ml 4% articaine hydrochloride with 1:100000 adrenaline injected in the mucobuccal fold opposite either the lower 1st molar, 2nd molar or canine tooth.
Placebo is needle penetration only.
Intervention typeOther
Primary outcome measureResponse to electronic pulp testing indicating pulpal anaesthesia
Secondary outcome measuresInjection discomfort using a Visual Analogue Scale
Overall study start date06/02/2012
Completion date31/07/2012

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
Upper age limit30 Years
SexBoth
Target number of participants22
Key inclusion criteriaVolunteers that are aged 18-30 years, with vital molar, first and second premolar, canine and incisor teeth that are not restored.
Key exclusion criteria1. Volunteers that are under 18 or over 30 years of age
2. Those unable to give consent
3. Those with self reported bleeding disorders, orofacial anaesthesia or paraesthesia, allergies to local anaesthetic drugs, preganancy at time of study or with teeth that respond negatively to baseline pulp testing or key test teeth missing
Date of first enrolment06/02/2012
Date of final enrolment31/07/2012

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Newcastle University
Newcastle Upon Tyne
NE2 4BW
United Kingdom

Sponsor information

Newcastle Hospitals NHS Foundation Trust (UK)
Hospital/treatment centre

Joint Research Office
Level 6, Leazes Wing
Royal Victoria Infirmary
Queen Victoria Road
Newcastle Upon Tyne
NE1 4LP
England
United Kingdom

Website http://www.newcastle-hospitals.org.uk/
ROR logo "ROR" https://ror.org/05p40t847

Funders

Funder type

Industry

M ESPE (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/04/2013 Yes No